diglycyl-histidine has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gyotoku, J; Kimoto, E; Morishige, F; Pauling, L; Tanaka, H | 1 |
| Liu, H; Pang, YH | 1 |
2 other study(ies) available for diglycyl-histidine and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Enhancement of antitumor activity of ascorbate against Ehrlich ascites tumor cells by the copper:glycylglycylhistidine complex.
Topics: Animals; Ascorbic Acid; Carcinoma, Ehrlich Tumor; Cell Survival; Copper; Drug Synergism; Electron Spin Resonance Spectroscopy; Kinetics; Mice; Oligopeptides; Oxidation-Reduction | 1983 |
[Effect of diglycylhistidine on the oxidation of ascorbate catalyzed by Cu(II)].
Topics: Animals; Ascitic Fluid; Ascorbic Acid; Carcinoma, Ehrlich Tumor; Copper; Mice; Oligopeptides; Oxidation-Reduction | 1989 |